Athenex, Inc.

BUFFALO, NY How do I update this listing?

Athenex is based out of Buffalo. Athenex, Inc. operates as a biopharmaceutical company. The Company offers discovery, development, and commercialization of novel therapies for the treatment of cancer. Athenex serves patients globally.Whalewisdom has at least 29 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2019-12-11. The notice included securities offered of Equity

Create Alert

Contact Info

athenex, inc.
1001 MAIN STREET
BUFFALO NY    14203

Business Phone: 716-898-8625
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-12-11 D PHARMACEUTICALS Equity 60,369,975 60,369,975 0
2019-05-15 D PHARMACEUTICALS Equity 100,000,000 100,000,000 0
2018-07-17 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 50,000,000 50,000,000 0
2017-05-03 D BIOTECHNOLOGY Debt 20,000,000 20,000,000 0
2016-10-07 D BIOTECHNOLOGY Debt 50,000,000 37,900,000 12,100,000
2015-06-16 D/A BIOTECHNOLOGY Equity INDEFINITE 74,399,996 INDEFINITE
2015-06-16 D BIOTECHNOLOGY Equity 10,000,016 10,000,016 0
2015-05-20 D BIOTECHNOLOGY Equity 62,799,990 48,099,980 14,700,010
2013-12-23 D BIOTECHNOLOGY Equity 40,000,000 300,000 39,700,000
2012-08-06 D BIOTECHNOLOGY Equity 40,000,000 5,000,000 35,000,000
2011-04-25 D OTHER TECHNOLOGY Equity 5,000,000 4,674,600 325,400
2010-02-03 D/A OTHER TECHNOLOGY Equity 6,000,000 4,075,000 1,925,000
2010-01-07 D OTHER TECHNOLOGY Equity 6,000,000 3,810,000 2,190,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALLEN BARNETT subscription required
    EXECUTIVE OFFICER DIRECTOR
ANTONY LEUNG subscription required
    DIRECTOR
BENSON KWAN HUNG TSANG subscription required
    DIRECTOR
CHARLES LANNON subscription required
    DIRECTOR
DAVID HANGAUER subscription required
    EXECUTIVE OFFICER
DAVID HSIA subscription required
    DIRECTOR
FLINT BESECKER subscription required
    DIRECTOR
JAMES HUSSEY subscription required
    EXECUTIVE OFFICER
JEAN-PIERRE SOMMADOSSI subscription required
    DIRECTOR
JEFFREY YORDON subscription required
    EXECUTIVE OFFICER
JINN WU subscription required
    DIRECTOR
JOHN KOH subscription required
    DIRECTOR
JOHN VIERLING subscription required
    DIRECTOR
JOHNSON LAU subscription required
    EXECUTIVE OFFICER DIRECTOR
JORDAN KANFER subscription required
    DIRECTOR
KIM CAMPBELL subscription required
    DIRECTOR
LI SHEN subscription required
    EXECUTIVE OFFICER
LYN DYSTER subscription required
    EXECUTIVE OFFICER
MANSON FOK subscription required
    DIRECTOR
MICHAEL MURPHY subscription required
    DIRECTOR
NICK RIEHLE subscription required
    EXECUTIVE OFFICER
RANDOLL SZE subscription required
    EXECUTIVE OFFICER
RUDOLF KWAN subscription required
    EXECUTIVE OFFICER
RUDOLPH KWAN subscription required
    EXECUTIVE OFFICER
SHELDON TRAINOR-DEGIROLAMO subscription required
    DIRECTOR
SIMON PEDDER subscription required
    EXECUTIVE OFFICER
SONG-YI ZHANG subscription required
    DIRECTOR
SONGYI ZHANG subscription required
    DIRECTOR
STEPHANIE DAVIS subscription required
    DIRECTOR
WILLIAM ZUO subscription required
    EXECUTIVE OFFICER

Elevate your investments